Cambridge, Mass. – Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the successful completion of a $135 million Series B financing. Proceeds from...
Funding & investments
The Four Key Elements to Scaling Health IT Startups
In the United States, we spend roughly double the dollars that other high-income nations do on healthcare, yet we have the lowest life expectancy and highest infant mortality rate. Something needs to be done, and the...
